Lion Biotechnologies Fund Predictions

NASDAQ Stock Exchange

Open Broker Account

$6.95

+0 (+0%)

At Close: Jan 16, 2018

Currently predicting for Wed, 8 May 2024

LBIO Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Lion Biotechnologies

Lion Biotechnologies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The companys lead product candidate is LN-144, an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) that is in Phase II clinical trial, which are T cells derived from patients tumors for the treatment of patients w... LBIO Profile

Golden Star

Ticker	Date	Change	Price
TMO	May 02	0.403%	$571.25
STNG	May 02	0.699%	$71.50
DLR	May 02	2.58%	$140.15
RF	May 02	0.97%	$19.64
INVH	May 02	0.87%	$34.50
SMAR	May 02	2.24%	$38.39
BIRK	May 02	0.650%	$44.61
FTSL	May 02	0.217%	$46.11
VCSH	May 02	0.287%	$76.71
VRNT	May 02	2.44%	$30.78

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In